Review
doi: 10.1056/NEJMra0707704.
EGFR antagonists in cancer treatment
Affiliations
- PMID: 18337605
- DOI: 10.1056/NEJMra0707704
Item in Clipboard
Review
EGFR antagonists in cancer treatment
N Engl J Med.
.
Erratum in
- N Engl J Med. 2009 Apr 9;360(15):1579
No abstract available
Similar articles
-
Epidermal growth factor receptor _targeted therapies for solid tumours.Acta Clin Belg. 2011 Jan-Feb;66(1):10-7. doi: 10.2143/ACB.66.1.2062508. Acta Clin Belg. 2011. PMID: 21485758 Review.
-
Exploring the future of non-small cell lung cancer treatment.Manag Care. 2005 Feb;14(2 Suppl):9-13; discussion 13-4. Manag Care. 2005. PMID: 15776956 No abstract available.
-
EGFR-directed therapies to treat non-small-cell lung cancer.Expert Opin Investig Drugs. 2009 Aug;18(8):1133-45. doi: 10.1517/13543780903066772. Expert Opin Investig Drugs. 2009. PMID: 19572809 Review.
-
Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4416s-4420s. doi: 10.1158/1078-0432.CCR-06-0555. Clin Cancer Res. 2006. PMID: 16857820 Review.
-
Epidermal growth factor receptor-_targeted treatment for advanced colorectal carcinoma.Cancer. 2005 Jun 15;103(12):2435-46. doi: 10.1002/cncr.21123. Cancer. 2005. PMID: 15880563 Review.
Cited by
-
Strategic insights into the cultivation of pancreatic cancer organoids from endoscopic ultrasonography-guided biopsy tissue.World J Gastroenterol. 2024 Nov 14;30(42):4532-4543. doi: 10.3748/wjg.v30.i42.4532. World J Gastroenterol. 2024. PMID: 39563744 Free PMC article.
-
Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents.RSC Adv. 2024 Oct 22;14(45):33384-33417. doi: 10.1039/d4ra05244g. eCollection 2024 Oct 17. RSC Adv. 2024. PMID: 39439843 Free PMC article. Review.
-
Receptor tyrosine kinases in breast cancer treatment: unraveling the potential.Am J Cancer Res. 2024 Sep 15;14(9):4172-4196. doi: 10.62347/KIVS3169. eCollection 2024. Am J Cancer Res. 2024. PMID: 39417188 Free PMC article. Review.
-
First-Line Therapy in Metastatic, RAS Wild-Type, Left-Sided Colorectal Cancer: Should Everyone Receive Anti-EGFR Therapy?Curr Oncol Rep. 2024 Nov;26(11):1489-1501. doi: 10.1007/s11912-024-01601-x. Epub 2024 Oct 11. Curr Oncol Rep. 2024. PMID: 39392559 Review.
-
Signaling pathways involved in colorectal cancer: pathogenesis and _targeted therapy.Signal Transduct _target Ther. 2024 Oct 7;9(1):266. doi: 10.1038/s41392-024-01953-7. Signal Transduct _target Ther. 2024. PMID: 39370455 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
